Active	Status	Sponsor type	Region	Phase	Filter
1 Active 8 Inactive 9 All	Not yet recruiting Recruiting Enrolling by invitation Active, not recruiting Available No longer recruiting	Industry lead sponsor Industry collaborator Coop Other Show only owner-sponsored trials	US Canada Japan Europe RoW	N/A 1 2 3 4	Highlight changes:- Show only changed items Enrollment:

Advanced Filters

1 Trials

Active Trials   

 

Export

Trial + Data / Events	Status	Ph	N	Region	Interventions	Sponsor	Conditions	Primary compl	Study compl
labetuzumab govitecan (IMMU-130) / Gilead
ACTRN12623001333606: Investigating the efficacy of an Adjuvant immunotherapy for preventing colorectal liver metastases - The CCaLM trial	Not yet recruiting	2	66			St George Hospital, St George Hospital (Trust Fund - Prof David Morris)	Colon cancer